Addex Therapeutics Ltd. (ADXN) Enterprise Value (2022 - 2024)

Addex Therapeutics' Enterprise Value history spans 3 years, with the latest figure at -$3.8 million for Q4 2024.

  • For Q4 2024, Enterprise Value rose 12.48% year-over-year to -$3.8 million; the TTM value through Dec 2024 reached -$3.8 million, up 12.48%, while the annual FY2024 figure was -$3.8 million, 11.76% up from the prior year.
  • Enterprise Value for Q4 2024 was -$3.8 million at Addex Therapeutics, up from -$4.4 million in the prior quarter.
  • Across five years, Enterprise Value topped out at -$3.8 million in Q4 2024 and bottomed at -$7.2 million in Q4 2022.
  • The 3-year median for Enterprise Value is -$4.4 million (2023), against an average of -$5.1 million.
  • The largest annual shift saw Enterprise Value surged 39.64% in 2023 before it grew 12.48% in 2024.
  • A 3-year view of Enterprise Value shows it stood at -$7.2 million in 2022, then soared by 39.64% to -$4.4 million in 2023, then grew by 12.48% to -$3.8 million in 2024.
  • Per Business Quant, the three most recent readings for ADXN's Enterprise Value are -$3.8 million (Q4 2024), -$4.4 million (Q4 2023), and -$7.2 million (Q4 2022).